Nimodipine vs. Milrinone – Equal or Complementary Use? A Retrospective Analysis
BackgroundCerebral vasospasm (CVS) continues to account for high morbidity and mortality in patients surviving the initial aneurysmal subarachnoid hemorrhage (SAH). Nimodipine is the only drug known to reduce delayed cerebral ischemia (DCI), but it is believed not to affect large vessel CVS. Milrino...
Guardat en:
| Autors principals: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2022-07-01
|
| Col·lecció: | Frontiers in Neurology |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fneur.2022.939015/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|